149861-83-6

Basic information

• Product Name: 1-((((7,7-dimethyl-2(S)-2(S)-((4-(1-tert-butoxycarbonyl)piperidinyl)amino)-4-(methylsulfonyl)butyramido)bicyclo<2.2.1>heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperazine
• Synonyms: 1-((((7,7-dimethyl-2(S)-2(S)-((4-(1-tert-butoxycarbonyl)piperidinyl)amino)-4-(methylsulfonyl)butyramido)bicyclo<2.2.1>heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperazine
• CAS NO: 149861-83-6
• Molecular Weight: 738.026
• Mol File: 149861-83-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1-((((7,7-dimethyl-2(S)-2(S)-((4-(1-tert-butoxycarbonyl)piperidinyl)amino)-4-(methylsulfonyl)butyramido)bicyclo<2.2.1>heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperazine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-((((7,7-dimethyl-2(S)-2(S)-((4-(1-tert-butoxycarbonyl)piperidinyl)amino)-4-(methylsulfonyl)butyramido)bicyclo<2.2.1>heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperazine(149861-83-6)
• EPA Substance Registry System: 1-((((7,7-dimethyl-2(S)-2(S)-((4-(1-tert-butoxycarbonyl)piperidinyl)amino)-4-(methylsulfonyl)butyramido)bicyclo<2.2.1>heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperazine(149861-83-6)

Safety Data

• Hazardous Substances Data: 149861-83-6(Hazardous Substances Data)

Upstream product

• 60280-45-7 N-Boc-L-methionine sulfone 
• 148927-58-6 1-(((7,7-dimethyl-2(S)-aminobicyclo<2.2.1>heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperazine 
• 148927-59-7 L 368845 
• 148927-57-5 1-(((7,7-dimethyl-2-oximinobicyclo<2.2.1>heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperazine 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 148927-60-0 L 368899 

Relevant articles and documents

1-(((7,7-Dimethyl-2(S)-(2(S)-amino-4- (methylsulfonyl)butyramido)bicyclo[2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4- (2-methylphenyl)piperazine (L-368,899): An orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm

Modifications to the previously reported spiroindenylpiperidine camphorsulfonamide oxytocin (OT) antagonist L-366,509 have produced a new series of o-tolylpiperazine (TP) camphorsulfonamides. A number of analogues in the TP series that incorporate a modif